Using indirect comparisons in pharmacoeconomic examination

Using indirect comparisons in pharmacoeconomic examination

Health technology assessment is a fundamental tool while choosing the most cost- and clinical effective technologies that are being introduced into the health system. The basis for assessment is the data of clinical studies. The experts are interested in not only the effect of a new medical technolo...

書目詳細資料
Main Authors:	Yu. E. Balykina, A. S. Kolbin
格式:	Article
語言:	Russian
出版:	IRBIS LLC 2015-03-01
叢編:	Фармакоэкономика
主題:	health technology assessment indirect comparisons comparative assessment
在線閱讀:	https://www.pharmacoeconomics.ru/jour/article/view/43

相似書籍

INDIRECT COMPARISONS IN HEALTH TECHNOLOGY ASSESSMENT
由: S. V. Goryajnov, et al.
出版: (2012-04-01)

Matching-Adjusted Indirect Comparisons in the assessment of hemato-oncological drugs
由: Francisco Javier Parrondo-García, et al.
出版: (2021-03-01)

Perceptions of indirect treatment comparisons as an evidence base in oncology decision-making: results of an international survey of health technology assessment and payer decision-makers
由: Ioannis Katsoulis, et al.
出版: (2024-11-01)

Letter in reply: network meta-analysis for indirect comparison of lanadelumab and for the treatment of hereditary angioedema
由: Maureen Watt, et al.
出版: (2024-04-01)

Matching-adjusted indirect comparison of guselkumab versus risankizumab in patients with moderate-to-severe plaque psoriasis: Change in baseline Psoriasis Area and Severity Index from week 4 to 40
由: Richard G. Langley, MD, et al.
出版: (2024-06-01)

Indirect treatment comparison of lanadelumab and a C1-esterase inhibitor in pediatric patients with hereditary angioedema
由: Maureen Watt, et al.
出版: (2025-01-01)

Evaluation of Bioequivalence of Generic Imatinib Products and Generic Tacrolimus Products Based on Indirect Comparison of the Results of Their Bioequivalence Studies
由: D. V. Goryachev, et al.
出版: (2019-09-01)

Comparative effectiveness of erenumab versus rimegepant for migraine prevention using matching-adjusted indirect comparison
由: Ronan Mahon, et al.
出版: (2024-03-01)

THE POSSIBILITIES AND RESULTS OF INDIRECT COMPARISON OF BIOLOGICAL AGENTS IN ANKYLOSING SPONDYLITIS
由: Sh. F. Erdes
出版: (2016-12-01)

Methods for Indirect Treatment Comparison: Results from a Systematic Literature Review
由: Bérengère Macabeo, et al.
出版: (2024-04-01)

EFFICACY AND SAFETY OF THE ORAL ANTICOAGULANTS IN THE MANAGEMENT OF VENOUS THROMBOEMBOLISM: INDIRECT COMPARISON
由: V. I. Petrov, et al.
出版: (2016-12-01)

Matching-Adjusted Indirect Comparison of Risankizumab Versus Deucravacitinib in Patients with Moderate-to-Severe Plaque Psoriasis
由: April W. Armstrong, et al.
出版: (2024-10-01)

Indirect comparison for Anti-TNF drugs in moderate to severe ulcerative colitis
由: M. Galván-Banqueri, et al.
出版: (2015-01-01)

Modern needs in health technology assessment: a study of comparative effectiveness
由: A. V. Pavlysh, et al.
出版: (2013-04-01)

Comparative efficacy of diroximel fumarate, ozanimod and interferon beta-1a for relapsing multiple sclerosis using matching-adjusted indirect comparisons
由: Tammy Jiang, et al.
出版: (2024-10-01)

RESULTS OF EVALUATING THE EFFICACY OF SECUKINUMAB VERSUS ADALIMUMAB IN TREATING PSORIATIC ARTHRITIS BY USING THE MATCHING-ADJUSTED INDIRECT COMPARISON METHOD
由: T. V. Korotaeva
出版: (2016-12-01)

Matching-Adjusted Indirect Comparison of the Efficacy at Week 32 of Tralokinumab and Dupilumab in the Treatment of Moderate-to-Severe Atopic Dermatitis
由: Tiago Torres, et al.
出版: (2024-04-01)

Matching-Adjusted Indirect Comparison of the Long-Term Efficacy Maintenance and Adverse Event Rates of Lebrikizumab versus Dupilumab in Moderate-to-Severe Atopic Dermatitis
由: Kim Rand, et al.
出版: (2023-10-01)

The socioeconomic burden of meningococcal infection in the Russian Federation
由: Yu. V. Lobzin, et al.
出版: (2024-12-01)

Matching-adjusted indirect comparison of efficacy and safety of lisocabtagene maraleucel and mosunetuzumab for the treatment of third-line or later relapsed or refractory follicular lymphoma
由: Loretta J. Nastoupil, et al.
出版: (2025-03-01)

Efficacy of Upadacitinib and Dupilumab on Achieving Stringent and Composite Skin and Itch Outcomes: an Indirect Comparison of Adults with Moderate-to-Severe Atopic Dermatitis
由: April W. Armstrong, et al.
出版: (2024-07-01)

Faricimab versus the standard of care for neovascular age-related macular degeneration in Italy: an indirect treatment comparison
由: Carlotta Galeone, et al.
出版: (2024-12-01)

Letter to the Editor Regarding ‘Matching-Adjusted Indirect Comparison of the Long-Term Efficacy Maintenance and Adverse Event Rates of Lebrikizumab Versus Dupilumab in Moderate-to-Severe Atopic Dermatitis’
由: Mike Bastian, et al.
出版: (2024-02-01)

Acupuncture versus tricyclic antidepressants in the prophylactic treatment of tension-type headaches: an indirect treatment comparison meta-analysis
由: Qing-Feng Tao, et al.
出版: (2024-04-01)

Comparison of several alternative uses of targeted antirheumatic drugs in monotherapy for early rheumatoid arthritis
由: O. V. Shatalova, et al.
出版: (2017-04-01)

Gastrointestinal adverse effects associated with the use of intravenous oliceridine compared with intravenous hydromorphone or fentanyl in acute pain management utilizing adjusted indirect treatment comparison methods
由: Joseph Biskupiak, et al.
出版: (2024-03-01)

EU HTA Joint Clinical Assessment: are patients with rare disease going to lose out?
由: Alejandra Castanon, et al.
出版: (2024-05-01)

A matching-adjusted indirect comparison of centanafadine versus lisdexamfetamine, methylphenidate and atomoxetine in adults with attention-deficit/hyperactivity disorder: long-term safety and efficacy
由: Jeff Schein, et al.
出版: (2024-08-01)

The Prominence Value of the Temporal Anchor of Free Indirect Discourse: A Comparison with the Perspectival Center
由: Jakob Egetenmeyer
出版: (2020-12-01)

What can we learn from international comparisons of health systems and health system reform?
由: Barbara McPake, et al.

Cost of epilepsy in the Russian Federation
由: A. S. Romanov, et al.
出版: (2024-10-01)

Matching-adjusted Indirect Comparison of Dermatology Life Quality Index 0/1 Response in Trials of Calcipotriol Plus Betamethasone Dipropionate Foam and Cream Formulations in Patients with Psoriasis
由: Ahmad Jalili, et al.
出版: (2024-02-01)

Pharmacoeconomic analysis of vemurafenib and dabrafenib use in patients with inoperable or metastatic melanoma with BRAF V600 mutation
由: A. S. Kolbin, et al.
出版: (2018-05-01)

Study of direct and indirect risk assessment of landslide impacts on ultrahigh-voltage electricity transmission lines
由: Chenchen Huang, et al.
出版: (2024-10-01)

The Direct and The Indirect as Paired Forensic Categories
由: Grigory S. Garbouz
出版: (2024-08-01)

Diagnostic Efficacy of 11 SARS‐CoV‐2 Serological Assays for COVID‐19: A Meta‐Analysis and Adjusted Indirect Comparison of Diagnostic Test Accuracy
由: Ying Zhao, et al.
出版: (2024-12-01)

Pharmacoeconomic analysis of the use of botulinum toxin in the treatment of poststroke spasticity
由: A. S. Kolbin, et al.
出版: (2018-05-01)

Matching-Adjusted Indirect Comparison of the 52-Week Efficacy of Bimekizumab Versus Secukinumab and Ixekizumab for the Treatment of Radiographic Axial Spondyloarthritis
由: Walter P. Maksymowych, et al.
出版: (2024-06-01)

¿A quién afecta el descrédito, sobre todo?
由: Juan Igartua Salaverria
出版: (2020-12-01)

Spatial Assessment and Comparison of Land Use in Karrada City, Iraq, Using Geographic Information Systems
由: Fathela Abwd Ali, et al.
出版: (2024-10-01)